The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Genomic Biomarker Market Research Report 2024
Synopsis
The global Genomic Biomarker market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Genomic Biomarker is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Genomic Biomarker is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Genomic Biomarker in Hospitals is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Genomic Biomarker include Bio-Rad, Beckman Coulter, Myriad Genetics, Thermo Fisher Scientific, Roche, QIAGEN, Epigenomics, Almac and Pfizer, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Genomic Biomarker, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Genomic Biomarker.
Report Scope
The Genomic Biomarker market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Genomic Biomarker market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Genomic Biomarker companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Bio-Rad
Beckman Coulter
Myriad Genetics
Thermo Fisher Scientific
Roche
QIAGEN
Epigenomics
Almac
Pfizer
Human Longevity
ValiRx
Personalis
Eagle Genomics
Empire Genomics
Agilent
Illumina
Segment by Type
Protein Marker
Nucleic Acid Marker
Other
Segment by Application
Hospitals
Diagnostic and research laboratories
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Genomic Biomarker companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
The global Genomic Biomarker market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Genomic Biomarker is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Genomic Biomarker is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Genomic Biomarker in Hospitals is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Genomic Biomarker include Bio-Rad, Beckman Coulter, Myriad Genetics, Thermo Fisher Scientific, Roche, QIAGEN, Epigenomics, Almac and Pfizer, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Genomic Biomarker, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Genomic Biomarker.
Report Scope
The Genomic Biomarker market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Genomic Biomarker market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Genomic Biomarker companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Bio-Rad
Beckman Coulter
Myriad Genetics
Thermo Fisher Scientific
Roche
QIAGEN
Epigenomics
Almac
Pfizer
Human Longevity
ValiRx
Personalis
Eagle Genomics
Empire Genomics
Agilent
Illumina
Segment by Type
Protein Marker
Nucleic Acid Marker
Other
Segment by Application
Hospitals
Diagnostic and research laboratories
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Genomic Biomarker companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Genomic Biomarker Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Protein Marker
1.2.3 Nucleic Acid Marker
1.2.4 Other
1.3 Market by Application
1.3.1 Global Genomic Biomarker Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospitals
1.3.3 Diagnostic and research laboratories
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Genomic Biomarker Market Perspective (2019-2030)
2.2 Genomic Biomarker Growth Trends by Region
2.2.1 Global Genomic Biomarker Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Genomic Biomarker Historic Market Size by Region (2019-2024)
2.2.3 Genomic Biomarker Forecasted Market Size by Region (2025-2030)
2.3 Genomic Biomarker Market Dynamics
2.3.1 Genomic Biomarker Industry Trends
2.3.2 Genomic Biomarker Market Drivers
2.3.3 Genomic Biomarker Market Challenges
2.3.4 Genomic Biomarker Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Genomic Biomarker Players by Revenue
3.1.1 Global Top Genomic Biomarker Players by Revenue (2019-2024)
3.1.2 Global Genomic Biomarker Revenue Market Share by Players (2019-2024)
3.2 Global Genomic Biomarker Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Genomic Biomarker Revenue
3.4 Global Genomic Biomarker Market Concentration Ratio
3.4.1 Global Genomic Biomarker Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Genomic Biomarker Revenue in 2023
3.5 Genomic Biomarker Key Players Head office and Area Served
3.6 Key Players Genomic Biomarker Product Solution and Service
3.7 Date of Enter into Genomic Biomarker Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Genomic Biomarker Breakdown Data by Type
4.1 Global Genomic Biomarker Historic Market Size by Type (2019-2024)
4.2 Global Genomic Biomarker Forecasted Market Size by Type (2025-2030)
5 Genomic Biomarker Breakdown Data by Application
5.1 Global Genomic Biomarker Historic Market Size by Application (2019-2024)
5.2 Global Genomic Biomarker Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Genomic Biomarker Market Size (2019-2030)
6.2 North America Genomic Biomarker Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Genomic Biomarker Market Size by Country (2019-2024)
6.4 North America Genomic Biomarker Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Genomic Biomarker Market Size (2019-2030)
7.2 Europe Genomic Biomarker Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Genomic Biomarker Market Size by Country (2019-2024)
7.4 Europe Genomic Biomarker Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Genomic Biomarker Market Size (2019-2030)
8.2 Asia-Pacific Genomic Biomarker Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Genomic Biomarker Market Size by Region (2019-2024)
8.4 Asia-Pacific Genomic Biomarker Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Genomic Biomarker Market Size (2019-2030)
9.2 Latin America Genomic Biomarker Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Genomic Biomarker Market Size by Country (2019-2024)
9.4 Latin America Genomic Biomarker Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Genomic Biomarker Market Size (2019-2030)
10.2 Middle East & Africa Genomic Biomarker Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Genomic Biomarker Market Size by Country (2019-2024)
10.4 Middle East & Africa Genomic Biomarker Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Bio-Rad
11.1.1 Bio-Rad Company Detail
11.1.2 Bio-Rad Business Overview
11.1.3 Bio-Rad Genomic Biomarker Introduction
11.1.4 Bio-Rad Revenue in Genomic Biomarker Business (2019-2024)
11.1.5 Bio-Rad Recent Development
11.2 Beckman Coulter
11.2.1 Beckman Coulter Company Detail
11.2.2 Beckman Coulter Business Overview
11.2.3 Beckman Coulter Genomic Biomarker Introduction
11.2.4 Beckman Coulter Revenue in Genomic Biomarker Business (2019-2024)
11.2.5 Beckman Coulter Recent Development
11.3 Myriad Genetics
11.3.1 Myriad Genetics Company Detail
11.3.2 Myriad Genetics Business Overview
11.3.3 Myriad Genetics Genomic Biomarker Introduction
11.3.4 Myriad Genetics Revenue in Genomic Biomarker Business (2019-2024)
11.3.5 Myriad Genetics Recent Development
11.4 Thermo Fisher Scientific
11.4.1 Thermo Fisher Scientific Company Detail
11.4.2 Thermo Fisher Scientific Business Overview
11.4.3 Thermo Fisher Scientific Genomic Biomarker Introduction
11.4.4 Thermo Fisher Scientific Revenue in Genomic Biomarker Business (2019-2024)
11.4.5 Thermo Fisher Scientific Recent Development
11.5 Roche
11.5.1 Roche Company Detail
11.5.2 Roche Business Overview
11.5.3 Roche Genomic Biomarker Introduction
11.5.4 Roche Revenue in Genomic Biomarker Business (2019-2024)
11.5.5 Roche Recent Development
11.6 QIAGEN
11.6.1 QIAGEN Company Detail
11.6.2 QIAGEN Business Overview
11.6.3 QIAGEN Genomic Biomarker Introduction
11.6.4 QIAGEN Revenue in Genomic Biomarker Business (2019-2024)
11.6.5 QIAGEN Recent Development
11.7 Epigenomics
11.7.1 Epigenomics Company Detail
11.7.2 Epigenomics Business Overview
11.7.3 Epigenomics Genomic Biomarker Introduction
11.7.4 Epigenomics Revenue in Genomic Biomarker Business (2019-2024)
11.7.5 Epigenomics Recent Development
11.8 Almac
11.8.1 Almac Company Detail
11.8.2 Almac Business Overview
11.8.3 Almac Genomic Biomarker Introduction
11.8.4 Almac Revenue in Genomic Biomarker Business (2019-2024)
11.8.5 Almac Recent Development
11.9 Pfizer
11.9.1 Pfizer Company Detail
11.9.2 Pfizer Business Overview
11.9.3 Pfizer Genomic Biomarker Introduction
11.9.4 Pfizer Revenue in Genomic Biomarker Business (2019-2024)
11.9.5 Pfizer Recent Development
11.10 Human Longevity
11.10.1 Human Longevity Company Detail
11.10.2 Human Longevity Business Overview
11.10.3 Human Longevity Genomic Biomarker Introduction
11.10.4 Human Longevity Revenue in Genomic Biomarker Business (2019-2024)
11.10.5 Human Longevity Recent Development
11.11 ValiRx
11.11.1 ValiRx Company Detail
11.11.2 ValiRx Business Overview
11.11.3 ValiRx Genomic Biomarker Introduction
11.11.4 ValiRx Revenue in Genomic Biomarker Business (2019-2024)
11.11.5 ValiRx Recent Development
11.12 Personalis
11.12.1 Personalis Company Detail
11.12.2 Personalis Business Overview
11.12.3 Personalis Genomic Biomarker Introduction
11.12.4 Personalis Revenue in Genomic Biomarker Business (2019-2024)
11.12.5 Personalis Recent Development
11.13 Eagle Genomics
11.13.1 Eagle Genomics Company Detail
11.13.2 Eagle Genomics Business Overview
11.13.3 Eagle Genomics Genomic Biomarker Introduction
11.13.4 Eagle Genomics Revenue in Genomic Biomarker Business (2019-2024)
11.13.5 Eagle Genomics Recent Development
11.14 Empire Genomics
11.14.1 Empire Genomics Company Detail
11.14.2 Empire Genomics Business Overview
11.14.3 Empire Genomics Genomic Biomarker Introduction
11.14.4 Empire Genomics Revenue in Genomic Biomarker Business (2019-2024)
11.14.5 Empire Genomics Recent Development
11.15 Agilent
11.15.1 Agilent Company Detail
11.15.2 Agilent Business Overview
11.15.3 Agilent Genomic Biomarker Introduction
11.15.4 Agilent Revenue in Genomic Biomarker Business (2019-2024)
11.15.5 Agilent Recent Development
11.16 Illumina
11.16.1 Illumina Company Detail
11.16.2 Illumina Business Overview
11.16.3 Illumina Genomic Biomarker Introduction
11.16.4 Illumina Revenue in Genomic Biomarker Business (2019-2024)
11.16.5 Illumina Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
